Praxis Precision Medicines, Inc. Common Stock
PRAX Real Time Price USDRecent trades of PRAX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PRAX's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators Nov. 19, 2024
-
Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof Sep. 03, 2024
-
Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof Jul. 30, 2024
-
Patent Title: Ion channel modulators Jul. 09, 2024
-
Patent Title: Compounds and their methods of use Mar. 05, 2024
-
Patent Title: Ion channel modulators Jan. 09, 2024
-
Patent Title: Compounds and their methods of use Oct. 03, 2023
-
Patent Title: Kcnt1 inhibitors and methods of use Oct. 03, 2023
-
Patent Title: Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators Sep. 26, 2023
-
Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator Aug. 22, 2023
-
Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator Aug. 22, 2023
-
Patent Title: Compounds and their methods of use Aug. 22, 2023
-
Patent Title: Hemi-citrate salts of gaba-a positive allosteric modulator and crystalline form thereof Jul. 11, 2023
-
Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof May. 16, 2023
-
Patent Title: Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity Apr. 18, 2023
-
Patent Title: Substituted pyridines as ion channel modulators Nov. 22, 2022
-
Patent Title: Compounds and their methods of use Nov. 08, 2022
-
Patent Title: Formulations of t-type calcium channel modulators and methods of use thereof Aug. 30, 2022
-
Patent Title: Ion channel modulators Mar. 22, 2022
-
Patent Title: Compounds and their methods of use Mar. 22, 2022
-
Patent Title: Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel Mar. 01, 2022
-
Patent Title: 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator May. 25, 2021
-
Patent Title: Salts and crystal forms of gaba Feb. 23, 2021
-
Patent Title: Salts and crystal forms of gaba Feb. 18, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of PRAX in WallStreetBets Daily Discussion
Recent insights relating to PRAX
Recent picks made for PRAX stock on CNBC
ETFs with the largest estimated holdings in PRAX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PRAX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.